<p><i>Tlr9</i><sup><i>-/-</i></sup> bone marrow was transduced with doxycycline inducible WT or Y870A HA-tagged TLR9, and differentiated towards DCs. Three days later, protein expression was induced by doxycycline (0.5μg/ml) treatment, and BMDCs were fixed and permeabilized at 4 hours post-Doxycycline treatment. The 4 h post-doxycycline fixed cells were labeled for HA and either the late endosome/lysosome marker LAMP1 (A), the ER marker Calreticulin (B), or the Golgi marker GM130 (C). In all cases, nuclei were labeled by DAPI. Each panel shows an image of both WT and Y870A-expressing BMDCs for each individual label, a merged image (Merged), and a colocalization image in which areas of overlap of the two markers, after thresholding by the me...
Toll like receptors (TLRs) share a conserved structure comprising the N-terminal ectodomain, a trans...
<p><b>A.</b> MACS-purified CD19<sup>+</sup> B cells from WT, TLR2<sup>–/–</sup>, and TLR4<sup>–/–</s...
<p><b>(A)</b> B-cells were treated with CpG-ODN (0.5 μg/ml) in the presence or absence of RA (200 nM...
<p><i>Tlr9</i><sup><i>-/-</i></sup> bone marrow was transduced with doxycycline inducible WT or Y870...
<p>(A) <i>Tlr9</i><sup><i>-/-</i></sup> bone marrow was transduced with WT or Y870A TLR9 and differe...
<p>(A) 293T cells were transfected with 4μg of HA-tagged WT TLR9, Y870F, or Y870A. Cells were untrea...
<p>(A, B) <i>Tlr9</i><sup><i>-/-</i></sup> BMDCs expressing HA-tagged TLR9 WT, Y870F, or Y870A were ...
Dendritic cell-specific transmembrane protein (DC-STAMP) has been first identified as an EST in a cD...
Dendritic cell-specific transmembrane protein (DC-STAMP) has been first identified as an EST in a cD...
<p>Phase contrast images show aggregation of tDCs typical of activated leukocytes after 24 hrs incub...
Purpose: Toll like receptor (TLR) engagement is primarily a function of the innate immune cells. The...
Toll-like Receptor 9 (TLR9) is an endosomal receptor found highly expressed in B cells and plasmacyt...
<p>(A) Fluorescence microscopic observation of Rv0652 binding on DCs. (i) DCs derived from WT, TLR2<...
<p>(<b>A</b>) Macrophages were harvested after treated without or with R848 (100 ng/ml) for 30 min. ...
<p>A representative dot plot of B2 cells (B220<sup>high</sup>CD23<sup>pos</sup>) analyses is shown. ...
Toll like receptors (TLRs) share a conserved structure comprising the N-terminal ectodomain, a trans...
<p><b>A.</b> MACS-purified CD19<sup>+</sup> B cells from WT, TLR2<sup>–/–</sup>, and TLR4<sup>–/–</s...
<p><b>(A)</b> B-cells were treated with CpG-ODN (0.5 μg/ml) in the presence or absence of RA (200 nM...
<p><i>Tlr9</i><sup><i>-/-</i></sup> bone marrow was transduced with doxycycline inducible WT or Y870...
<p>(A) <i>Tlr9</i><sup><i>-/-</i></sup> bone marrow was transduced with WT or Y870A TLR9 and differe...
<p>(A) 293T cells were transfected with 4μg of HA-tagged WT TLR9, Y870F, or Y870A. Cells were untrea...
<p>(A, B) <i>Tlr9</i><sup><i>-/-</i></sup> BMDCs expressing HA-tagged TLR9 WT, Y870F, or Y870A were ...
Dendritic cell-specific transmembrane protein (DC-STAMP) has been first identified as an EST in a cD...
Dendritic cell-specific transmembrane protein (DC-STAMP) has been first identified as an EST in a cD...
<p>Phase contrast images show aggregation of tDCs typical of activated leukocytes after 24 hrs incub...
Purpose: Toll like receptor (TLR) engagement is primarily a function of the innate immune cells. The...
Toll-like Receptor 9 (TLR9) is an endosomal receptor found highly expressed in B cells and plasmacyt...
<p>(A) Fluorescence microscopic observation of Rv0652 binding on DCs. (i) DCs derived from WT, TLR2<...
<p>(<b>A</b>) Macrophages were harvested after treated without or with R848 (100 ng/ml) for 30 min. ...
<p>A representative dot plot of B2 cells (B220<sup>high</sup>CD23<sup>pos</sup>) analyses is shown. ...
Toll like receptors (TLRs) share a conserved structure comprising the N-terminal ectodomain, a trans...
<p><b>A.</b> MACS-purified CD19<sup>+</sup> B cells from WT, TLR2<sup>–/–</sup>, and TLR4<sup>–/–</s...
<p><b>(A)</b> B-cells were treated with CpG-ODN (0.5 μg/ml) in the presence or absence of RA (200 nM...